Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Nitric Oxide and Neuroprotection in Premature Infants

NCT00515281 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00515281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00515281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Nitric Oxide and Neuroprotection in Premature Infants
Lead sponsor
University of Chicago
Phase
Phase 2/3
Overall status
Terminated
Start date
May 31, 2008
Completion date
November 28, 2023
Enrollment
273 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, intraventricular hemorrhage, periventricular leukomalacia, prematurity